BIO-Europe Spring 2019: INKEF Capital: Investing In Health, Technology And The Gaps In Between
Executive Summary
Roel Bulthuis, managing partner of INKEF Capital, talks to In Vivo’s executive editor Lucie Ellis about the group’s €500m fund and where INKEF is placing its bets in biotech.